Needle core biopsy (NCB), as part of triple assessment for preoperative evaluation and
diagnosis of breast cancer, is now considered as an established, highly accurate method for …

Background The need for sentinel lymph node (SLN) biopsy in patients with a preoperative
diagnosis of ductal carcinoma in situ (DCIS) is debated. Advocates recommend such biopsy …

Purpose To perform a meta-analysis to report pooled estimates for underestimation of
invasive breast cancer (where core-needle biopsy [CNB] shows ductal carcinoma in situ …

Abstract Background Approximately 8–56% of patients with a core needle biopsy (CNB)
diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive disease at the time …

Fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) are widely used in
diagnosing breast lesions, with both achieving high sensitivity and specificity. Whether …

Objectives To evaluate whether apparent diffusion coefficient (ADC) parameters could
identify invasive components in cases with ductal carcinoma in situ (DCIS) diagnosed by …

Objectives This study investigated whether texture-based imaging parameters could identify
invasive components of ductal carcinoma in situ (DCIS). Methods We enrolled 65 biopsy …

The diagnosis of ductal carcinoma in situ (DCIS) using core biopsy does not ensure the
absence of invasion on final excision. We performed a retrospective analysis of 255 patients …

Diagnosis and management of ductal carcinoma in situ (DCIS). - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

Purpose Ductal carcinoma in situ (DCIS) is a non-invasive cancerous breast lesion;
however, from 10% to 50% of patients with DCIS diagnosed by core needle biopsy (CNB) or …